Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Insulin Aspart”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00184600
What this trial is testing

Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 708
Large-scale testing (Phase 3)Study completedNCT00617565
What this trial is testing

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 219
Post-approval studies (Phase 4)Study completedNCT02272296
What this trial is testing

Reliability of Insulin by Jet Injection

Who this might be right for
Diabetes Mellitus
Radboud University Medical Center 30
Post-approval studies (Phase 4)Study completedNCT04409587
What this trial is testing

Basal Insulin Glycemic ControL With DEglugec vs Aspart Via Pump

Who this might be right for
Type1 Diabetes Mellitus
Mountain Diabetes and Endocrine Center 59
Not applicableStudy completedNCT00729898
What this trial is testing

Observational Study to Observe the Safety of NovoMix® 30 Treatment in Patients With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 243
Not applicableStudy completedNCT00410033
What this trial is testing

Comparison of Antibody Levels in Children and Adolescents After Initiation of Insulin Therapy by Either Insulin Aspart or Soluble Human Insulin

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 74
Large-scale testing (Phase 3)Study completedNCT02500706
What this trial is testing

Efficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 1,108
Not applicableStudy completedNCT00675493
What this trial is testing

Observational Study of Type 1 and Type 2 Diabetes Patients Having Switched From Human Premixes to NovoMix®30

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 942
Large-scale testing (Phase 3)Study completedNCT02825251
What this trial is testing

Efficacy and Safety of Continuous Subcutaneous Insulin Infusion of Faster-acting Insulin Aspart Compared to NovoRapid® in Adults With Type 1 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 472
Post-approval studies (Phase 4)WithdrawnNCT00906529
What this trial is testing

Aggressive Versus Conservative Blood Glucose Control in Hospitalized Type 2 Diabetic Patients Using Detemir and Aspart Insulin

Who this might be right for
Type 2 Diabetes
University of Texas Southwestern Medical Center
Post-approval studies (Phase 4)Study completedNCT00791895
What this trial is testing

Efficacy of Biphasic Insulin Aspart 30 in Type 2 Diabetics Failing on OADs

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 102
Not applicableStudy completedNCT03895515
What this trial is testing

Effect of Fiasp® in Type 1 Diabetes Treatment

Who this might be right for
Diabetes Mellitus, Type 1
Novo Nordisk A/S 178
Large-scale testing (Phase 3)Study completedNCT01513590
What this trial is testing

A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 394
Large-scale testing (Phase 3)Study completedNCT01059812
What this trial is testing

A Pan Asian Trial Comparing Efficacy and Safety of NN5401 and Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 424
Post-approval studies (Phase 4)Study completedNCT00537303
What this trial is testing

Comparison of the Blood Sugar Lowering Effect and Safety of Two Insulin Treatments in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 296
Early research (Phase 1)Study completedNCT00992537
What this trial is testing

Comparison of the Effect of NN5401 With the Effect of NN1250 and Insulin Aspart in Type 1 Diabetics

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 27
Not applicableStudy completedNCT00696995
What this trial is testing

An Observational Study of Type 2 Diabetes in Patients Starting on NovoMix® 30 Treatment

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 509
Not applicableStudy completedNCT00873639
What this trial is testing

Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues

Who this might be right for
DiabetesDiabetes Mellitus, Type 1
Novo Nordisk A/S 417
Post-approval studies (Phase 4)UnknownNCT00747409
What this trial is testing

Insulin Effects on Metabolism and Cardiovascular Function in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Munich Municipal Hospital 120
Large-scale testing (Phase 3)Study completedNCT01365507
What this trial is testing

Efficacy and Safety of Insulin Degludec/Insulin Aspart in Insulin-naïve Subjects With Type 2 Diabetes Using Two Dosing Regimens

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 276
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation